High levels of FGF-23 and reduction of circulating Klotho levels in CKD correlate with a variety of clinical conditions such as left ventricular hypertrophy, vascular calcifications, and even an increased risk of mortality [12] in CKD patients. This evidence concerns the gene FGF23 and chronic kidney disease.